Search Results - "Bantel, H."

Refine Results
  1. 1

    Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection by Wandrer, F., Han, B., Liebig, S., Schlue, J., Manns, M. P., Schulze‐Osthoff, K., Bantel, H.

    Published in Alimentary pharmacology & therapeutics (01-08-2018)
    “…Summary Background Chronic viral hepatitis is linked to fibrotic liver injury that can progress to liver cirrhosis with its associated complications. Recent…”
    Get full text
    Journal Article
  2. 2

    Liver stiffness measurement using acoustic radiation force impulse elastography in overweight and obese patients by Attia, D., Bantel, H., Lenzen, H., Manns, M. P., Gebel, M. J., Potthoff, A.

    Published in Alimentary pharmacology & therapeutics (01-08-2016)
    “…Summary Background Obesity and overweight are global health problems. Aim To evaluate the diagnostic accuracy of liver stiffness measurement (LSM) using…”
    Get full text
    Journal Article
  3. 3

    Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach by Flanagan, L, Meyer, M, Fay, J, Curry, S, Bacon, O, Duessmann, H, John, K, Boland, K C, McNamara, D A, Kay, E W, Bantel, H, Schulze-Bergkamen, H, Prehn, J H M

    Published in Cell death & disease (04-02-2016)
    “…Colorectal cancer (CRC) is one of the most common cancers in the Western world. 5-Fluorouracil (5FU)-based chemotherapy (CT) remains the mainstay treatment of…”
    Get full text
    Journal Article
  4. 4

    Apoptosis in hepatitis C virus infection by Bantel, H, Schulze-Osthoff, K

    Published in Cell death and differentiation (01-01-2003)
    “…Infection with hepatitis C virus (HCV) is characterized by inflammatory liver damage and a long viral persistence associated with an increased risk of…”
    Get full text
    Journal Article
  5. 5

    Serum cell death biomarker mirrors liver cancer regression after transarterial chemoembolisation by Bock, B., Hasdemir, D., Wandrer, F., Rodt, T., Manns, M. P., Schulze‐Osthoff, K., Bantel, H.

    Published in Alimentary pharmacology & therapeutics (01-10-2016)
    “…Summary Background Hepatocellular carcinoma (HCC) represents an increasing health problem with limited therapeutic options. In patients with intermediate…”
    Get full text
    Journal Article
  6. 6

    Letter: cytokeratin‐18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors’ reply by Bantel, H., Wandrer, F., Bock, B., Kirstein, M. M., Schulze‐Osthoff, K.

    Published in Alimentary pharmacology & therapeutics (01-01-2017)
    “…Linked Content This article is linked to Bock et al and He et al papers. To view these articles visit https://doi.org/10.1111/apt.13578 and…”
    Get full text
    Journal Article
  7. 7

    Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity by Siegemund, M, Pollak, N, Seifert, O, Wahl, K, Hanak, K, Vogel, A, Nussler, A K, Göttsch, D, Münkel, S, Bantel, H, Kontermann, R E, Pfizenmaier, K

    Published in Cell death & disease (01-04-2012)
    “…Although targeting of the death receptors (DRs) DR4 and DR5 still appears a suitable antitumoral strategy, the limited clinical responses to recombinant…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome by John, K, Wielgosz, S, Schulze-Osthoff, K, Bantel, H, Hass, R

    Published in Cell death & disease (01-10-2013)
    “…HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome represents a life-threatening pregnancy disorder with high fetal and maternal mortality, but…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases by Canbay, A, Feldstein, A, Kronenberger, B, Schulze-Osthoff, K, Bantel, H

    Published in Zeitschrift fur Gastroenterologie (01-03-2014)
    “…Currently liver biopsy represents the gold standard to assess severity and fibrosis grade in liver diseases. Since this laborious, costly, and invasive…”
    Get more information
    Journal Article
  19. 19

    Staphylococcus aureus alpha-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation by Essmann, F, Bantel, H, Totzke, G, Engels, I H, Sinha, B, Schulze-Osthoff, K, Jänicke, R U

    Published in Cell death and differentiation (01-11-2003)
    “…Recent data suggest that alpha-toxin, the major hemolysin of Staphylococcus aureus, induces cell death via the classical apoptotic pathway. Here we…”
    Get full text
    Journal Article
  20. 20

    First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology by Weiss, J, Rau, M, Bantel, H, Bock, H, Demir, M, Kluwe, J, Krawczyk, M, Pathil-Warth, A, Schattenberg, J M, Tacke, F, Roeb, E, Geier, A

    Published in Zeitschrift fur Gastroenterologie (01-06-2015)
    “…Non-alcoholic fatty liver disease (NAFLD) currently is one oft the most common reasons for chronic liver injury in the western world. In the European and…”
    Get more information
    Journal Article